2) indinavir
茚地那韦
1.
Relative bioavailability of two formulations of indinavir in Chinese healthy volunteers by reversed phase high performance liquid chromatography;
反相高效液相色谱法测定茚地那韦2种制剂在健康人体的相对生物利用度(英文)
2.
LC/MS/MS determination of indinavir in human plasma;
LC/MS/MS测定人血浆中茚地那韦的浓度
3.
Effects of Wuzhi capsule on pharmacokinetics of indinavir;
五酯胶囊对茚地那韦在比格犬体内药代动力学的影响
3) indinavir sulfate
硫酸茚地那韦
1.
Pharmacokinetics and bioequivalence of indinavir sulfate capsules in healthy volunteers;
硫酸茚地那韦胶囊的人体药动学及生物等效性
2.
Study on HPLC determination of indinavir sulfate capsules in human plasma and its pharmacokinetics;
硫酸茚地那韦的人体药动学
3.
Relative bioavailability of domestic and imported indinavir sulfate capsules in Chinese healthy volunteers;
国产与进口硫酸茚地那韦胶囊在健康人体的相对生物利用度
4) Indinavir sulfate tablets
硫酸茚地那韦片
6) Nelfinavir
奈非那韦
1.
Novel Synthesis and Spectral Characterization of Nelfinavir;
奈非那韦的新法合成及其光谱表征
2.
As the anti-HIV-1 agents call trigger mechanisms involved in chemoresistance,to test whether prolonged in vitro treatment of Jurkat cell s with nelfinavir alters sensitivity of lymphoma cells to antitumor agents used fo r AIDS-associated maliglancies.
目的 体外研究奈非那韦耐性细胞株对其它抗艾滋病药及抗癌药的反应及与细胞凋亡的关系。
补充资料：茚地那韦
分子式：暂无
分子量：暂无
CAS号：157810-81-6
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：157810-81-6
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条